A subset (MEST, PLAGL1, PEG3, DLK1, IGF2) showed elevated expression in various embryonal cancers, especially rhabdomyosarcoma, as compared to non-embryonal cancers and normal tissues. This evidence concerns the gene IGF2 and embryonal neoplasm.